Adaptive Biotechnologies Corp - Common Stock (ADPT)
CUSIP: 00650F109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 151,803,139
- Total 13F shares
- 148,178,882
- Share change
- -4,701,169
- Total reported value
- $1,726,248,551
- Put/Call ratio
- 15%
- Price per share
- $11.65
- Number of holders
- 240
- Value change
- -$46,396,273
- Number of buys
- 138
- Number of sells
- 88
Quarterly Holders Quick Answers
What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00650F109:
Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
20%
|
29,993,708
|
$222,853,250 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
13D/G
|
Company |
4.1%
from 13D/G
|
13,117,851
|
$97,465,633 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.1%
|
12,229,793
|
$90,867,364 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
11,143,428
|
$82,795,671 | — | 31 Mar 2025 | |
| ARK Investment Management LLC |
13F
13D/G
|
Company |
2.9%
from 13D/G
|
7,732,570
|
$57,452,995 | — | 31 Mar 2025 | |
| Amova Asset Management Americas, Inc. |
13D/G
13F
|
Nikko Asset Management Americas, Inc. · Company |
4.6%
|
6,833,137
|
$53,981,782 | $0 | 31 Dec 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13D/G
13F
|
Company |
4.6%
|
6,833,137
|
$53,981,782 | $0 | 31 Dec 2024 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
4.3%
|
6,292,634
|
$49,711,809 | $0 | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
4.4%
|
6,642,476
|
$49,354,901 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
3.2%
|
4,803,794
|
$35,692,189 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
2,995,301
|
$22,255,086 | — | 31 Mar 2025 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
1.9%
|
2,941,212
|
$21,853,205 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,780,824
|
$20,666,002 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
2,689,543
|
$19,983,304 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.5%
|
2,306,312
|
$17,135,898 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
2,152,335
|
$15,991,849 | — | 31 Mar 2025 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
1.4%
|
2,145,145
|
$15,938,427 | — | 31 Mar 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
1.4%
|
2,134,061
|
$15,856,073 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.3%
|
2,005,940
|
$14,904,134 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
2,005,444
|
$14,900,449 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
1,764,227
|
$13,108,207 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.97%
|
1,471,553
|
$10,933,639 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.94%
|
1,424,672
|
$10,586,895 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.85%
|
1,295,117
|
$9,622,719 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.84%
|
1,268,574
|
$9,425,505 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.79%
|
1,197,622
|
$8,898,331 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
1,125,261
|
$8,360,697 | — | 31 Mar 2025 | |
| Pier Capital, LLC |
13F
|
Company |
0.72%
|
1,097,387
|
$8,153,585 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.71%
|
1,084,183
|
$8,055,480 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
1,053,590
|
$7,828,174 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.68%
|
1,027,267
|
$7,633,000 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.61%
|
930,972
|
$6,917,122 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
922,742
|
$6,855,973 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.42%
|
637,985
|
$4,740,229 | — | 31 Mar 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.41%
|
621,712
|
$4,619,320 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.41%
|
618,175
|
$4,593,040 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.4%
|
611,639
|
$4,544,478 | — | 31 Mar 2025 | |
| Clearline Capital LP |
13F
|
Company |
0.39%
|
586,380
|
$4,356,803 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.36%
|
552,531
|
$4,105,306 | — | 31 Mar 2025 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.35%
|
527,960
|
$3,922,743 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.34%
|
514,164
|
$3,820,239 | — | 31 Mar 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.3%
|
457,015
|
$3,395,622 | — | 31 Mar 2025 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.25%
|
376,736
|
$2,799,148 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
358,068
|
$2,660,442 | — | 31 Mar 2025 | |
| PDT Partners, LLC |
13F
|
Company |
0.23%
|
344,978
|
$2,563,187 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
310,272
|
$2,264,985 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.19%
|
288,467
|
$2,143,310 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.19%
|
285,135
|
$2,118,553 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.19%
|
284,781
|
$2,115,923 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
275,617
|
$2,047,834 | — | 31 Mar 2025 |
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q2 2025
As of 30 Jun 2025,
Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
148,178,882 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, Rubric Capital Management LP, Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., ARK Investment Management LLC, BRAIDWELL LP, AMERIPRISE FINANCIAL INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
222
Q2 2025 holders
240
Holder diff
18
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.